B

Bionanoplus

11 employees

Bionanoplus focuses on the development of polymeric nanoparticles and microparticles as controlled release drug delivery systems.

Basic info

Industry

nanotechnology research

Sectors

Encapsulation
Biotechnology
Dermatology
Vaccination
Drug Delivery
Disruptive Technology
IVRT
Hair Loss
Onychomycosis
Smart textiles
Health Diagnostics
Controlled Release
Innovation
Health Care
Polymeric nanoparticles
Intellectual property
Franz Diffusion Cells
Agriculture
Skin
Nanotechnology

Date founded

2010

Funding rounds raised

Total raised

$818K

from 2 investors over 2 rounds

B

Bionanoplus raised $818K on February 19, 2011

Investors: Start Up Capital Navarra, S.A. and Inveready

FAQ